research

Sickled cell
In the Lab

‘It’s the disparity in who gets affected’: A sickle cell doctor tracks dollars and drug development

By Elizabeth Cooney

COVID-19 CT scan
Health Tech

Debate flares over using AI to detect Covid-19 in lung scans

By Casey Ross and Rebecca Robbins

France_Hydroxychloroquine
Health

What if hydroxychloroquine doesn’t work? What if it does? Right now, we don’t know

By Matthew Herper

biopharma lab
In the Lab

What it’s like to go into the lab at a biopharma company during the coronavirus pandemic

By Rebecca Robbins and Kate Sheridan

location services
Health Tech

Can location data from smartphones help slow the coronavirus? Facebook is giving academics a chance to try

By Rebecca Robbins

chloroquine production line
Health

Why President Trump is at odds with his medical experts over using malaria drugs against Covid-19

By Matthew Herper

Stanford University main quad
Biotech

Near-lockdown in the Bay Area ‘ratchets up’ challenges for local biotechs and labs

By Rebecca Robbins

Regeneron
Biotech

Regeneron says potential Covid-19 drugs could start human tests by early summer

By Matthew Herper

CORD-19
Health Tech

To spur new AI tools to fight coronavirus, tech leaders launch open database of scientific articles

By Rebecca Robbins

Broad Institute signage
Health

Coronavirus pandemic forces some research labs to shut down, with uncertain futures for scientific projects

By Andrew Joseph

covid19_U.S. patient
Pharmalot

A new paper about a Gilead drug to combat coronavirus has some analysts skittish about success

By Ed Silverman

crushed pill/red background
Pharmalot

Danish regulator eyes sanctions — including prison time — against trial sponsors that fail to post results

By Ed Silverman

Fusobacterium nucleatum micrograph
Biotech

Microbial signatures in the blood could offer new avenue for liquid biopsies to detect cancer

By Rebecca Robbins

Clinical Trials illo
Pharmalot

Coronavirus fears may slow clinical trials and delay regulatory steps

By Ed Silverman

Testing generic drugs
Pharmalot

Clinical research company sued over stolen trade secrets after employee filmed dogs used in experiments

By Ed Silverman

stat madness
Don't Miss

STAT Madness voting ends tonight. Cast your vote for the best innovations in biomedicine

By STAT

money in syringe vaccine
First Opinion

A coronavirus vaccine should be for everyone, not just those who can afford it

By Gavin Yamey

U-M RPNI study
In the Lab

Surgery and AI give amputees more precise control of a prosthetic hand, study shows

By Shraddha Chakradhar

hallway doctor "power of yet"
First Opinion

Doctors need to embrace the ‘power of yet’

By Sue Ferrara

pharmaceutical_lab Bethesda, Maryland
Pharmalot

New estimate says developing a drug costs $1.3 billion, which is a lot, but less than companies often say

By Ed Silverman and Matthew Herper

Magnifying glass for precision medicine
First Opinion

Precision medicine: course correction urgently needed

By Richard Cooper and Nigel Paneth

coronavirus research ethics
First Opinion

Research in the time of coronavirus: keep it ethical

By Beatriz da Costa Thomé and Heidi Larson

Todd Mercer clinical trials
Biotech

Turned away from five clinical trials, a cancer patient waits for one that will take him

By Rebecca Robbins, Damian Garde, and Adam Feuerstein

Alzheimer's Tau imaging
In the Lab

They have ‘Alzheimer’s brains’ but no symptoms. A new wave of drug developers wants to know why

By Sharon Begley

Health Tech

Researchers develop AI-based intervention for kids with autism

By Shafaq Zia

clipboard
Health

Federal judge rules clinical trial sponsors must publish a decade’s worth of missing data

By Lev Facher

Google b&w
Health Tech

Google research suggests efforts to anonymize patient data aren’t foolproof

By Erin Brodwin

tdap vaccine
Health

Most adults don’t need booster vaccinations for tetanus and diphtheria, new study concludes

By Elizabeth Cooney

Aetion Carolyn Magill
Pharma

New partnership tries to make up for missing drug data in cost-effectiveness analyses

By Matthew Herper

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy